1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCenter for Antiviral Medicines and Pandemic Preparedness (CAMPP) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), NIH. CAMPP is a new antiviral drug development center that will focus on the discovery and development of next-generation drugs to combat coronaviruses and other viruses with pandemic potential.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern Award Recipients | NIAID: National Institute of Allergy and Infectious Diseases Resources for Researchers Division of Intramural Research Labs Research at Vaccine Research Center Intramural Scientist & Clinician Directory Research Rules & Policies Allergy, Immunology & Transplantation Resources for Researchers Antimicrobial (Drug) Resistance Antimicrobial Resistance Threats Information for Researchers Risk Factors & Prevention Research Immune Tolerance Processes Disease-Specific Research Information for Researchers Autoimmune Lymphoproliferative Syndrome (ALPS) Basic & Preclinical Research Information for Researchers Information for Researchers Shiga Toxin-Producing E.
coli (STEC) Researching Ebola in Africa Information for Researchers Information for Researchers Why Food Allergy is a Priority for NIAID Characterizing Food Allergy & Addressing Related Disorders Information for Researchers Diagnosis & Management Guidelines Disease-Specific Research Information for Researchers Genomics & Advanced Technologies Pathogen-Based Initiatives Information for Researchers Information for Researchers Group A Streptococcal Infections Disease-Specific Research Information for Researchers Overview of the Immune System Features of an Immune Response Information for Researchers Information for Researchers Leprosy (Hansen's Disease) How NIAID is Addressing Lyme Disease Information for Researchers Parasite, Mosquito & Human Host Prevention, Treatment & Control Strategies Strategic Partnerships & Research Capacity Information for Researchers Information for Researchers Neglected Tropical Diseases Information for Researchers Translational & Clinical Research Cross-cutting Preparedness Molecular & Genetic Research Primary Immune Deficiency Diseases (PIDDs) Information for Researchers Animal Prion Diseases and Humans Information for Researchers Respiratory Syncytial Virus (RSV) Schistosomiasis (Bilharzia) Research in Endemic Regions Sexually Transmitted Infections (STIs) NIAID's Research Approach Information for Researchers Disease-Specific Research Information for Researchers Information for Researchers Disease-Specific Vaccines Information for Researchers Translational & Clinical Research Information for Researchers Biology, Genetics & Clinical Research NIAID's Approach to Women's Health Research Sex-Specific Health Challenges Facing Women Biennial Report (FY 2019-2020) Information for Researchers Why NIAID Is Researching Zika Virus Information for Researchers Find a Funding Opportunity Opportunities & Announcements NIAID Research Priorities Plan Your Budget & Personnel Additional Application Elements Research with Special Considerations After You Submit an Application Funding Policies and Considerations Understand the Review Process Respond to Pre-Award Requests Negotiation & Initial Award Become a Healthy Volunteer Participant's Guide to Clinical Trials HIV and Emerging Infectious Diseases Laboratory of Infectious Diseases Primary Immune Deficiency Clinic Vaccine Research Center Clinical Studies Fill Out the Volunteer Form Q&A: Vaccine Clinical Studies Vaccine Clinical Studies Safeguards Clinical Trial Publications NIAID-Funded Research News Division of Allergy, Immunology, and Transplantation Division of Microbiology and Infectious Diseases Division of Extramural Activities Division of Clinical Research Division of Intramural Research Dr. Joseph J.
Kinyoun: Father of the NIH Dr. Joseph Kinyoun The Indispensable Forgotten Man Dr. Joseph Kinyoun: Selected Bibliography NIAID 60th Anniversary Timeline Research Training at NIAID Campuses Grant Programs that NIAID Funds AIDS Research Advisory Committee AIDS Vaccine Research Subcommittee Board of Scientific Counselors Members Advisory and Peer Review Committees Autoimmune Diseases Committee Website Policies and Notices External Link Icon and Disclaimers Freedom of Information Act (FOIA) Voluntarily Submitted Information Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern Menu Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern Award Recipients AI-Driven Structure-Enabled Antiviral Platform (ASAP) Principal Investigators: John Chodera, Ph.
D. ; Benjamin Perry, Ph. D.
; Alpha Lee, Ph. D. Institutes: Sloan Kettering Institute of Cancer Research; Drugs for Neglected Diseases Initiative; PostEra, Inc. Antiviral Countermeasures Development Center (AC/DC) Principal Investigators: George Painter, Ph.
D. ; Richard Plemper, Ph. D.
Institutes: Emory University; Georgia State University Center for Antiviral Medicines & Pandemic Preparedness (CAMPP) Principal Investigators: Sumit Chanda, Ph. D. ; Arnab Chatterjee, Ph.
D; Adolfo García-Sastre, Ph. D. Institutes: Scripps Research Institute; Calibr; Icahn School of Medicine at Mt.
Sinai Development of Outpatient Antiviral Cocktails against SARS-CoV-2 and other Potential Pandemic RNA Viruses Principal Investigator: Jeffrey Glenn, M. D. , Ph.
D. Institute : Stanford University Metropolitan AntiViral Drug Accelerator Principal Investigators: David Perlin, Ph. D.
; Charles Rice, Ph. D. Institute: Hackensack University Medical Center; The Rockefeller University Principal Investigators: Reuben Harris, Ph.
D. ; Fang Li, Ph. D.
Institute: University of Minnesota QCRG Pandemic Response Program Principal Investigator: Nevan Krogan, Ph. D. Institute: University of California, San Francisco Rapidly Emerging Antiviral Drug Development Initiative – AViDD Center (READDI-AC) Principal Investigators: Ralph Baric, Ph.
D. ; Timothy Willson, Ph. D.
Institute: The University of North Carolina at Chapel Hill UTMB-Novartis Alliance for Pandemic Preparedness Principal Investigators: Pei-Yong Shi, Ph. D. ; Thierry Diagana, Ph.
D. Institutes: The University of Texas Medical Branch; Novartis Institute of Biomedical Research, Inc. Content last reviewed on June 17, 2022
According to the current listing, eligibility includes: Scripps Research leads the center, with participants including Icahn School of Medicine at Mount Sinai, Washington University in St. Confirm the full requirements in the official notice before applying.
Center for Antiviral Medicines and Pandemic Preparedness (CAMPP) is funded by National Institute of Allergy and Infectious Diseases (NIAID), NIH. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Washington. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
National Institute of Allergy and Infectious Diseases (NIAID) Resource-Related Research Projects (R24 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), NIH. This program supports resource development projects to advance infectious disease and immunology research, aligning with NIAID's vision to improve human health through an integrated approach to infectious and immune-mediated disease research.
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), NIH. This funding opportunity supports investigator-initiated clinical trials requiring enhanced oversight, with durations up to 7 years, relevant to the NIAID mission of improving human health through infectious and immune-mediated disease research.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read article